Interstitial Lung Disease Registry Study: Prospective and Retrospective Observational Study in Austria

Launched by LUDWIG BOLTZMANN INSTITUTE FOR LUNG HEALTH · Jul 22, 2024

Keywords

ClinConnect Summary

The Interstitial Lung Disease Registry Study is focused on understanding interstitial lung disease, a condition that affects the lungs and can cause breathing difficulties. This study aims to collect important information about patients' health over time, including how they are treated, how well their lungs are functioning, and any side effects from their medications. By gathering this data, researchers hope to learn more about the disease and improve care for future patients.

If you have been diagnosed with interstitial lung disease and can give written consent, you may be eligible to participate in this study. There are no additional treatments involved in this registry; it simply involves sharing your health information. Participants will help researchers by allowing them to track their symptoms and progress, which could lead to better understanding and management of the disease for everyone. It's important to note that those who cannot understand or assess their participation in the study may not be eligible.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • diagnosis of interstitial lung disease
• • written informed consent
• Exclusion Criteria:
• • to not comprehend and rightfully judge participation